Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 4/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | ACP1 | P24666 | 1/20 | 0.33 |
| ▸ | CDC25B | P30305 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16950162 | 0.81 | PTPN1 (0.43) | MAPTPTPN1ACP1CDC25B | |
| SCHEMBL16950194 | 0.80 | TSHR (0.42) | USP2GAATSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL7403091 | 0.68 | LMNA (0.59) | TSHRALDH1A1SMN1; SMN2HPGDKDM4E | |
| SCHEMBL7961617 | 0.66 | GAA (0.40) | USP2GAATSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL1844172 | 0.66 | GAA (0.40) | USP2GAATSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL28132958 | 0.65 | HPGD (0.50) | USP2GAATSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL7961619 | 0.65 | GAA (0.42) | USP2GAATSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL27380646 | 0.64 | GAA (0.43) | USP2GAATSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL407103 | 0.61 | ALDH1A1 (0.51) | USP2GAATSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL7400068 | 0.59 | EGFR (0.44) | USP2GAATSHRALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150250169-A1 | ASCORBIC ACID-RELATED COMPOUND AND PLANT ANTIVIRAL AGENT | NIPPON SODA CO., LTD. (JP) | 2015-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150250169-A1 | ASCORBIC ACID-RELATED COMPOUND AND PLANT ANTIVIRAL AGENT | CBR3, OSR1, OXSR1 | USP2 2927/4885GAA 2766/4885TSHR 1757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.